signs

289th ENMC international workshop: assessing and managing emerging AAV related toxicities after gene therapy for neuromuscular disorders, 26 – 28 September 2025, Hoofddorp, The Netherlands

Background and Context The advent of adeno-associated virus (AAV) vectors has marked a significant milestone in the domain of gene

289th ENMC international workshop: assessing and managing emerging AAV related toxicities after gene therapy for neuromuscular disorders, 26 – 28 September 2025, Hoofddorp, The Netherlands Read Post »

When Guillain-Barre syndrome is not monophasic: Distinguishing recurrent Guillain-Barre syndrome from acuteonset chronic inflammatory demyelinating polyneuropathy and nodopathies

Overview of Recurrent Guillain-Barre Syndrome Recurrent Guillain-Barre Syndrome (RGBS) presents a unique challenge in neurology, distinguished by multiple episodes of

When Guillain-Barre syndrome is not monophasic: Distinguishing recurrent Guillain-Barre syndrome from acuteonset chronic inflammatory demyelinating polyneuropathy and nodopathies Read Post »

Scroll to Top